Article Sidebar

PDF
Date Published: 31/07/2022
Abstract Views: 343
Views PDF: 174
DOI: https://doi.org/10.51298/vmj.v516i2.3040
Issue
Vol. 516 No. 2 (2022)
Section
Các bài báo
How to Cite
Xuân Hậu, N. ., & Xuân Hiền, N. . (2022). THE CLINICAL – SUBCLINICAL CHARACTERISTICS IN PATIENTS WITH THYROID CANCER WHO WERE TREATED BY TOETVA. Vietnam Medical Journal, 516(2). https://doi.org/10.51298/vmj.v516i2.3040

THE CLINICAL – SUBCLINICAL CHARACTERISTICS IN PATIENTS WITH THYROID CANCER WHO WERE TREATED BY TOETVA

Nguyễn Xuân Hậu1,2,, Nguyễn Xuân Hiền2
1 Hanoi Medical University
2 Hanoi Medical University Hospital

Main Article Content

Abstract

Objects: To evaluate the clinical – paraclinical characteristics in patientswith thyroid cancer who were treated by TOETVA in Hanoi Medical University Hospital. Subjects and Methods: A prospective study was performed on 360 eligible patients who underwent TOETVA due to thyroid cancer in Department of Oncology and Palliative Care, Hanoi Medical University Hospital from July 2018to April 2021. The clinical, surgical, and pathological characteristics were recorded. Results: The mean age was 35.5±9.1 years. The average tumor size was 8.2±5.3 (2.6 – 27.0)mm. Most of the tumors were found in 1 lobe of the thyroid gland, the rate of tumors in both thyroid lobes was 12.7%. There were 38 patients (10.5%) having lymph nodes detected on ultrasound. 71.9% of the patients hadfine needle aspiration resultsthyroid cancer or suspected thyroid cancer. 16.1% and 83.9% of patients underwent total thyroidectomy and lobectomy with prophylactic central cervical lymph node dissection respectively. Mean surgical time ofTOETVAwas 96.7±24.9 min. Conclusions: TOETVA was applied in patietns with early stage of thyroid cancer.

Article Details

Keywords

transoral endoscopic thyroidectomy vestibular approach

References

1. Bray F., Ferlay J., Soerjomataram I., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
2. Nguyễn Văn Hiếu (2015), Ung thư học, Nhà xuất bản y học.
3. Chong K.-H., Wu M.-H., and Lai C.-W. (2020). Comparison of surgical outcome between conventional open thyroidectomy and endoscopic thyroidectomy through axillo-breast approach. Tzu Chi Med J, 32(3), 286.
4. Anuwong A. (2016). Transoral Endoscopic Thyroidectomy Vestibular Approach: A Series of the First 60 Human Cases. World J Surg, 40(3), 491–497.
5. Xuan H.N., Le H.T., Xuan H.N., et al. (2021). Preliminary Experience with Transoral Endoscopic Thyroidectomy and Parathyroidectomy via Vestibular Approach. 25(1), 11.
6. Nguyen H.X., Nguyen H.X., Nguyen H.V., et al. (2021). Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques, 31(4), 410–415.
7. Anuwong A., Ketwong K., Jitpratoom P., et al. (2018). Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg, 153(1), 21.
8. Kim S.Y., Kim S.-M., Makay Ö., et al. (2020). Transoral endoscopic thyroidectomy using the vestibular approach with an endoscopic retractor in thyroid cancer: experience with the first 132 patients. Surg Endosc, 34(12), 5414–5420.
9. Ahn J. and Yi J.W. (2020). Transoral endoscopic thyroidectomy for thyroid carcinoma: outcomes and surgical completeness in 150 single-surgeon cases. Surg Endosc, 34(2), 861–867.